Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.35 |
| ▸ | FDPS | P14324 | 3/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16335522 | 1.00 | MAPT (0.43) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL3897049 | 1.00 | MAPT (0.43) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL6934258 | 1.00 | MAPT (0.43) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL4316886 | 0.98 | MAPT (0.40) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL6937132 | 0.95 | MAPT (0.43) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL7755470 | 0.91 | MAPT (0.43) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL1057388 | 0.91 | MAPT (0.43) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL6937735 | 0.91 | MAPT (0.39) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL6934654 | 0.91 | MAPT (0.43) | MAPTLMNADNM1TSHRTHRB | |
| SCHEMBL7755502 | 0.90 | DNM1 (0.36) | MAPTLMNADNM1TSHRFDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114805822-B | Polymer molecular brush with multiblock side chains and preparation method and application thereof | 南京大学 | 2023-06-06 | — | — | CN | claimed |
| CN-118317992-A | Dual UV blocker comprising a shelf-life stable photoactive bulk polymerized polycycloolefin composition as an optical material | 普罗米鲁斯有限责任公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-118302462-A | Polymer composition and single layer phase difference material | 日产化学株式会社 | 2024-07-05 | — | — | CN | disclosed |
| CN-112424253-B | Bulk polymerization of polyoxazolidinones | 巴斯夫欧洲公司 | 2024-02-27 | — | — | CN | disclosed |
| US-20240060177-A1 | INDIUM COMPOUND, THIN-FILM FORMING RAW MATERIAL, THIN FILM, AND METHOD OF PRODUCING SAME | ADEKA CORPORATION (JP) | 2024-02-22 | — | — | US | disclosed |
| CN-116848170-A | Photoactive bulk polymerized polycycloolefin compositions as optical materials that are shelf-life stable for extended periods of time | 普罗米鲁斯有限责任公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116457380-A | Improved polycycloolefin compositions having stable shelf life and capable of bulk polymerization | 普罗米鲁斯有限责任公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-112335252-B | Polycycloolefin monomer as 3D printing material and catalyst activated by compound capable of generating photoacid | 住友电木株式会社 | 2023-07-04 | — | — | CN | disclosed |
| CN-114938648-B | Stable bulk polymerized polycycloolefin compositions as three-dimensional printing materials and methods of making same | 住友电木株式会社 | 2023-06-30 | — | — | CN | disclosed |
| CN-116368165-A | Polycyclic olefin composition for low loss films with improved thermal properties | 普罗米鲁斯有限责任公司 | 2023-06-30 | — | — | CN | disclosed |
| US-20080287684-A1 | Method for Producing Ionic Liquids | BASF SE (DE) | 2008-11-20 | — | — | US | disclosed |
| US-20080269477-A1 | Solvent System Based on Molten Ionic Liquids, Its Production and Use for Producing Regenerated Carbohydrates | BASF SE (DE) | 2008-10-30 | — | — | US | disclosed |
| US-20080190321-A1 | Cellulose Solutions in Ionic Liquids | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-14 | — | — | US | disclosed |
| US-20080164440-A1 | Solubility of Cellulose in Ionic Liquids With Addition of Amino Bases | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-10 | — | — | US | disclosed |
| WO-2008043837-A1 | IONIC LIQUIDS FOR SOLUBILIZING POLYMERS | BASF SE (DE) | 2008-04-17 | — | — | WO | disclosed |
| CN-101160325-A | Cellulose solution in ionic liquid | BASF AG (DE) | 2008-04-09 | — | — | CN | disclosed |
| US-20080028777-A1 | Novel Pairs Of Working Substances For Absorption Heat Pumps, Absorption Refrigeration Machines And Heat Transformers | BASF AKTIENGESELLSCHAFT (DE) | 2008-02-07 | — | — | US | disclosed |
| US-20080033209-A1 | Method For High-Purity Quaternary Ammonium Compounds | BASF AKTIENGSELLSCHAFT (DE) | 2008-02-07 | — | — | US | disclosed |
| US-20080009633-A1 | Method for Producing High-Purity Quaternary Ammonium Compounds | BASF AKTIENGESELLSCHAFT (DE) | 2008-01-10 | — | — | US | disclosed |
| US-20060149074-A1 | Method for the production of purified 1,3-substituted imidazolium salts | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287684-A1 | Method for Producing Ionic Liquids | HACL2, HAO2, SLC6A12 | MAPT 1705/4885LMNA 765/4885DNM1 1906/4885 |
| US-20060149074-A1 | Method for the production of purified 1,3-substituted imidazolium salts | HIRA, HAO2, HACL2 | MAPT 4012/4885LMNA 386/4885DNM1 3532/4885 |
| US-20240060177-A1 | INDIUM COMPOUND, THIN-FILM FORMING RAW MATERIAL, THIN FILM, AND METHOD OF PRODUCING SAME | ARGLU1, RNF5, LUC7L2 | MAPT 3312/4885LMNA 1301/4885DNM1 3506/4885 |
| US-20080033209-A1 | Method For High-Purity Quaternary Ammonium Compounds | ATL3, SMYD3, SP1 | MAPT 3527/4885LMNA 1973/4885DNM1 1304/4885 |
| US-20080009633-A1 | Method for Producing High-Purity Quaternary Ammonium Compounds | SP1, EIF3A, EIF3H | MAPT 3429/4885LMNA 1884/4885DNM1 698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.